Invention Grant
- Patent Title: Anti-CD115 antibodies
-
Application No.: US15760322Application Date: 2016-09-16
-
Publication No.: US10759861B2Publication Date: 2020-09-01
- Inventor: John Lippincott , Dana Duey
- Applicant: ABLEXIS, LLC
- Applicant Address: US CA San Diego
- Assignee: Ablexis, LLC
- Current Assignee: Ablexis, LLC
- Current Assignee Address: US CA San Diego
- Agency: Haley Guiliano LLP
- Agent James F. Haley, Jr.; Brian M. Gummow
- International Application: PCT/US2016/052063 WO 20160916
- International Announcement: WO2017/049038 WO 20170323
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
The present invention provides anti-CD115 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic and diagnostic methods for the treatment of cancer, autoimmune, and other diseases.
Public/Granted literature
- US10723801B2 Anti-CD115 antibodies Public/Granted day:2020-07-28
Information query
